Patient Square Capital LP Portfolio Holdings

Patient Square Capital LP

  • $215 Billion
  • Q2 2024

Patient Square Capital LP has filed its 13F form on August 13, 2024 for Q2 2024 where it was disclosed a total value porftolio of $215 Billion distributed in 2 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Roivant Sciences Ltd. with a value of $129B and Liquidia Corp with a value of $86.2B.

Examining the 13F form we can see an decrease of $19.4B in the current position value, from $235B to 215B.

Patient Square Capital LP is based out at Menlo Park, CA

Below you can find more details about Patient Square Capital LP portfolio as well as his latest detailed transactions.

Portfolio value $215 Billion
Healthcare: $215 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$8.3B
$129 Billion 59.99% of portfolio
12,228,465
Q1 2024 Reduced 3.26%
$709M
$86.2 Billion 40.01% of portfolio
7,182,532
Q1 2024 New

Summary

  • Portfolio
  • No. of Stocks 2
  • Current Value $215 Billion
  • Prior Value $235 Billion
  • Filing
  • Period Q2 2024
  • Filing Date August 13, 2024
  • Form Type 13F-HR
  • Activity in Q2 2024
  • New Purchases 0 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Patient Square Capital LP Portfolio

Follow Patient Square Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patient Square Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Patient Square Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email